Clinical Trials Directory

Trials / Completed

CompletedNCT05822648

Evaluating a Type 2 Diabetes Prevention Program

Evaluating a Brief Type 2 Diabetes Prevention Program With Greater Scalability

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
62 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study aims to test the effectiveness of a Type 2 Diabetes (T2D) prevention program for individuals who have been diagnosed with prediabetes compared to a T2D educational control group. Project health is an obesity prevention program and has produced a 42% to 53% reduction in future onset of overweight/obesity and also produced greater reductions in negative affect compared to assessment-only controls that persisted. Project Health has been adapted to prevent onset of T2D among individuals with prediabetes. The study aims to test the effectiveness of Project Health at reducing BMI, HbA1c levels, increase physical activity and improve glucose control.

Conditions

Interventions

TypeNameDescription
BEHAVIORALProject HealthProject Health will be delivered in six 1-hour group sessions that will be held weekly. In addition, participants will be asked to complete 30 mins of response inhibition and attention trainings once per week between the sessions. This program promotes to retain the gradual lifestyle modification designed to bring energy intake into balance with energy output and the food response inhibition and attention training, but will adapt the dissonance-induction activities to focus on the negative effects of developing T2D in addition to the negative effects of obesity, overeating, and a sedentary lifestyle.
OTHEREducational Video ControlWe selected a T2D management psychoeducational comparison condition. To match Project Health, the educational videos will be delivered in 6 1-hour blocks. The educational group will be instructed to watch videos on nutrition, exercise, and how to maintain general health during the lifespan

Timeline

Start date
2023-04-15
Primary completion
2024-04-22
Completion
2024-04-22
First posted
2023-04-21
Last updated
2025-04-04
Results posted
2025-04-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05822648. Inclusion in this directory is not an endorsement.